Universal Axon Clinical Research, LLC | Doral, FL logo

Universal Axon Clinical Research, LLC | Doral, FL

Research site
Location
3650 North West 82 Ave Suite 503, Doral, Florida, United States of America
Site insights

Top conditions

Crohn Disease (4 trials)

Ulcerative Colitis (4 trials)

Ulcer (4 trials)

Colitis (4 trials)

Urinary Tract Infections (3 trials)

Top treatments

Upadacitinib
ABT-494
Risankizumab
fezolinetant
Vericiguat
AZD7442
MK-1242
EDP-305
Linzagolix
VERU-944

Data sourced from clinicaltrials.gov

Contact this site

Albert Garcia

Verified by this site

Trials

15 of 36
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

This is a longitudinal follow-up study of the RC-002 study, in which up to 246 subjects assigned to two randomization arms will be enrolled: an adipo...

Invitation-only
Partial Thickness Rotator Cuff Tear
Device: Corticosteroid
Device: Adipose Derived Regenerative Cells

This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.

Enrolling
Crohn Disease
Drug: Ozanimod
Other: Placebo

The study consists of 4 sub-studies, as follows:Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safety...

Active, not recruiting
Crohn's Disease
Drug: Risankizumab SC
Drug: Risankizumab On-Body Injector (OBI)

The purpose of this study is to demonstrate the efficacy of 9-valent extraintestinal pathogenic Escherichia coli vaccine (ExPEC9V) compared to placeb...

Enrolling
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Biological: ExPEC9V
Other: Placebo

The purpose of this study is to evaluate the efficacy and safety of vericiguat in participants with chronic heart failure with reduced ejection fract...

Active, not recruiting
Chronic Heart Failure With Reduced Ejection Fraction
Drug: Vericiguat
Drug: Placebo

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety an...

Active, not recruiting
Cytomegalovirus Infection
Biological: mRNA-1647
Biological: Placebo

This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not respon...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: Placebo
Drug: Upadacitinib (ABT-494)

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vaccine is compared to...

Enrolling
COVID-19
Influenza
Biological: Placebo
Biological: Influenza and COVID-19 Combination B

The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...

Active, not recruiting
Atopic Dermatitis
Drug: Upadacitinib
Drug: Placebo for Upadacitinib

The purpose of this investigation is to evaluate the safety and superior effectiveness in functional improvement in patients with partial-thickness r...

Active, not recruiting
Rotator Cuff Tear
Rotator Cuff Tendinitis
Device: Adipose Derived Regenerative Cells
Drug: Corticosteroid

The purpose of the present study is to assess the efficacy of secukinumab 300 mg s.c. (subcutaneous) compared to placebo, each in combination with st...

Enrolling
Rotator Cuff Tendinopathy
Drug: Secukinumab
Drug: Placebo

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Enrolling
Endometriosis
Drug: Placebo
Drug: Combined Oral Contraceptive

This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic...

Active, not recruiting
Contraception
Device: ESSURE (BAY1454032)
Procedure: Laparoscopic tubal sterilization

This is a multicenter, randomized, double-blind, placebo-controlled, dose-response trial in patients with chronic stable Heart Failure (HF) and reduc...

Enrolling
Reduced Ejection Fraction
Heart Failure
Drug: INL1
Other: Placebo

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting
Lower Respiratory Tract Illness
Biological: Placebo
Biological: RSVpreF

Trial sponsors

AbbVie logo

AbbVie (8 trials)

F

Freenome (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems